Ruthenium-enhanced curcumin derivatives target tumor growth and cancer-related inflammation in head and neck cancer models

These findings highlight their potential not only as stand-alone therapeutic agents but also as adjuvants in combination therapies for HNC.

Authors

Robert Kaplánek (ORCID: https://orcid.org/0000-0002-5759-882X)
Jan Hajduch (ORCID: https://orcid.org/0000-0003-3715-6626)
Kateřina Veselá (ORCID: https://orcid.org/0000-0002-2908-8101)
Milan Jakubek (ORCID: https://orcid.org/0000-0001-7323-3903)
Zdeněk Kejík (ORCID: https://orcid.org/0000-0002-2215-4890)
Kateřina Kučnirová (ORCID: https://orcid.org/0000-0002-7090-7578)
Nikita Abramenko (ORCID: https://orcid.org/0000-0001-6184-2947)
Petr Babula (ORCID: https://orcid.org/0000-0003-2389-2868)
Ameneh Tatar (ORCID: https://orcid.org/0000-0001-8513-2106)
Pavel Martásek (ORCID: https://orcid.org/0000-0002-0839-8370)